This H.B. Fuller Company Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

Comments
Loading...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Needham analyst Bernie McTernan downgraded Beyond, Inc. BYON from Buy to Hold and maintained the price target of $9. Beyond shares closed at $5.90 on Tuesday. See how other analysts view this stock.
  • Morgan Stanley analyst Patrick Wood downgraded Tandem Diabetes Care, Inc. TNDM from Overweight to Equal-Weight and lowered the price target from $45 to $22. Tandem Diabetes Care shares closed at $19.49 on Tuesday. See how other analysts view this stock.
  • Seaport Global analyst Michael Harrison downgraded H.B. Fuller Company FUL from Buy to Neutral. H.B. Fuller shares closed at $54.94 on Tuesday. See how other analysts view this stock.
  • Mizuho analyst Maheep Mandloi downgraded Sunnova Energy International Inc. NOVA from Outperform to Neutral and lowered the price target from $11 to $1. Sunnova Energy Intl shares closed at $0.6748 on Tuesday. See how other analysts view this stock.
  • Scotiabank analyst Daniel Tricarico downgraded the rating for CubeSmart CUBE from Sector Outperform to Sector Perform and lowered the price target from $52 to $46. CubeSmart shares closed at $41.80 on Tuesday. See how other analysts view this stock.

Read This Next:

BYON Logo
BYONBeyond Inc
$3.56-5.94%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
3.39
Growth
4.85
Quality
-
Value
75.75
Price Trend
Short
Medium
Long
Got Questions? Ask
Which stocks could benefit from H.B. Fuller's downgrade?
How might Beyond, Inc rebound after the downgrade?
What potential does Tandem Diabetes Care hold after its rating change?
Which competitors of Sunnova Energy might gain market share?
Could CubeSmart's downgrade create buying opportunities?
How will healthcare stocks react to Tandem's rating adjustment?
What are the implications for energy stocks after Sunnova's downgrade?
Which investment funds are most exposed to H.B. Fuller?
How might analyst downgrades affect overall market sentiment?
What sectors could see investment shifts following these downgrades?
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm

Posted In: